Sisco, E.
and Barnes, K.
(2021),
Design, Synthesis, and Biological Evaluation of Novel 1,3-Oxazole Sulfonamides as Tubulin Polymerization Inhibitors, ACS Medicinal Chemical Letters, [online], https://doi.org/10.1021/acsmedchemlett.1c00219, https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=932076
(Accessed December 14, 2024)
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Design, Synthesis, and Biological Evaluation of Novel 1,3-Oxazole Sulfonamides as Tubulin Polymerization Inhibitors
Published
Author(s)
, Korry Barnes
Abstract
A series of novel 1,3-oxazole sulfonamides were constructed and screened for their potential to inhibit cancer cell growth. These compounds were evaluated against the full NCI-60 human tumor cell lines; with the majority exhibiting promising overall growth inhibitory properties. They displayed high specificity within the panel of leukemia cell lines vs. all other lines tested. When examined in the dose-response assay GI50 values fell within the low micromolar to nanomolar ranges. 1,3-oxazole sulfonamide 16 displayed the best average growth inhibition, while the 2-chloro-5-methyl (44) and 1-naphthyl (58) analogues proved to be the most potent leukemia inhibitors with mean GI50 values of 48.8 and 44.7 nanomolar respective-ly. In vitro tubulin polymerization experiments revealed that this class of compounds effectively binds to tubulin and induc-es depolymerization of microtubules within cells.Citation
ACS Medicinal Chemical Letters
Volume
12
Issue
6
Pub Type
Journals
Download Paper
Keywords
Small molecules, anticancer drug leads, sulfonamides, heterocycles, oxazoles
Citation
Issues
If you have any questions about this publication or are having problems accessing it, please contact reflib@nist.gov.
Created June 17, 2021, Updated November 29, 2022